Quick Answer
GRI Bio, Inc. reported Stockholders Equity of $6.01 million for fiscal year 2025.
GRI Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $6.01M | +49.0% |
| 2024 | $4.03M | +1456.8% |
| 2023 | $259.0K | +115.9% |
| 2022 | -$1.62M | +66.5% |
| 2021 | -$4.85M | -233.4% |
| 2020 | -$1.45M | -145.2% |
| 2019 | $3.21M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.99M | -45.5% | -40.0% |
| June 30, 2025 | $3.32M | -29.6% | +175.7% |
| March 31, 2025 | $1.21M | -56.9% | -70.1% |
| December 31, 2024 | $4.03M | +1456.8% | +10.2% |
| September 30, 2024 | $3.66M | +64.3% | -22.4% |
| June 30, 2024 | $4.72M | +16.9% | +68.7% |
| March 31, 2024 | $2.80M | +186.6% | +980.3% |
| December 31, 2023 | $259.0K | +115.9% | -88.4% |
- GRI Bio, Inc. showed an increase of +49.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, GRI Bio, Inc.’s stockholders equity has grown by 86.9% (from $3.21 million to $6.01 million).
- The most recent figure is from GRI Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: